Hungary - Hungary - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

ratiopharm hungária kft. - oxaliplatin -

Jerman - Jerman - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ratiopharm gmbh (3087881) - oxaliplatin - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; oxaliplatin (29849) 5 milligramm

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

alembic pharmaceuticals limited - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution is contraindicated in neonates and infants (under the age of 2 years). brimonidine tartrate ophthalmic solution is contraindicated in patients who have exhibited a hypersensitivity reaction to any component of this medication in the past. pregnancy category b: teratogenicity studies have been performed in animals. brimonidine tartrate was not teratogenic when given orally during gestation days 6 through 15 in rats and days 6 through 18 in rabbits. the highest doses of brimonidine tartrate in rats (2.5 mg/kg/day) and rabbits (5.0 mg/kg/day) achieved auc exposure values 360- and 20-fold higher, or 260- and 15-fold higher, respectively, than similar values estimated in humans treated with brimonidine tartrate ophthalmic solution 0.15%,1 drop in both eyes three

Switzerland - Jerman - Swissmedic (Swiss Agency for Therapeutic Products)

acino pharma ag - amoxicillinum anhydricum, säure clavulanicum - pulver zur herstellung einer suspension zum einnehmen - amoxicillinum anhydricum 125 mg ut amoxicillinum trihydricum, acidum clavulanicum 31.25 mg ut kalii clavulanas, silica colloidalis anhydrica, xanthani gummi, crospovidonum, carmellosum natricum, aromatica (erdbeer) cum alcohol benzylicus et propylenglycolum, aspartamum 8.32 mg, ad suspensionem corresp. suspensio reconstituta 5 ml corresp. natrium max. 2.35 mg. - infektionskrankheiten - synthetika

Denmark - Denmark - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - florasulam, diflufenican - suspensionskoncentrat - 50 g/l florasulam ; 500 g/l diflufenican

Denmark - Denmark - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - florasulam - suspensionskoncentrat - 50 g/l florasulam

Denmark - Denmark - SEGES Landbrug & Fødevarer

basf a/s - picolinafen, pendimethalin - suspensionskoncentrat - 16 g/l picolinafen ; 320 g/l pendimethalin

Denmark - Denmark - SEGES Landbrug & Fødevarer

fmc agricultural solutions a/s (tidligere: cheminova a/s) - epoxiconazol - suspensionskoncentrat - 125 g/l epoxiconazol

Belgium - Perancis - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - chlorhydrate de bétaxolol 2,8 mg/g - eq. bétaxolol 2,5 mg/g - collyre en suspension - 2,5 mg/ml - chlorhydrate de bétaxolol 2.8 mg/g - betaxolol